Molnupiravir
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir
Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.
Commenting on the development, Dr Satyanarayana Chava, Founder and CEO, Laurus Labs said, "We are happy to sign an agreement to manufacture the oral Covid-19 antirviral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission."
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
